Carboplatin/Etoposide/VismodegibLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2032卷 / 1期

关键词：

D O I：

10.1007/s40278-024-69772-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：111 / 111

相关论文

共 50 条

[11] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2021, 1856 (1) : 126 - 126
[12] Carboplatin/etoposide/vincristineLack of efficacy: case report
Reactions Weekly, 2024, 2035 (1) : 134 - 134
[13] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1927 (1) : 154 - 154
[14] Carboplatin/etoposide/imatinibLack of efficacy: case report
Reactions Weekly, 2022, 1912 (1) : 135 - 135
[15] Carboplatin/etoposide/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 128 - 128
[16] Carboplatin/Etoposide/IfosfamideLack of efficacy: case report
Reactions Weekly, 2024, 2024 (1) : 121 - 121
[17] Carboplatin/Etoposide/VincristineLack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 104 - 104
[18] Carboplatin/etoposide/temozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1936 (1) : 134 - 134
[19] Carboplatin/etoposide/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1917 (1) : 155 - 155
[20] VismodegibLack of efficacy: case report
Reactions Weekly, 2021, 1874 (1) : 257 - 257

← 1 2 3 4 5 →